Medindia

X

Allergan Battles Medicis in the Hyaluronic Acid Filler Market

Wednesday, November 21, 2007 General News J E 4
Advertisement
WALTHAM, Mass., Nov. 20 Millennium Research Group's FacialAesthetic Marketrack results indicate that since the January launch ofAllergan's hyaluronic acid (HA) Juvederm product line, the company's marketshare increased to over 15% in the US from Q1 to Q3.

HA is a naturally occurring substance that can be found in cells, skin,and joint cushions in nearly all organisms. For cosmetic uses, HA is injectedwith fine syringes into patients' skin. The product is used to fill inwrinkles (for example, smile lines around the mouth) and to increase volume inthe lips, cheeks, and chin.

"While Medicis Pharmaceutical remains the strongest competitor in thedermal filler market, Allergan's Juvederm product line is increasingcompetition," says Jennifer Thomas, Analyst at Millennium Research Group."Even though there is lively contest for share, the facial aesthetic marketoverall continues to expand and benefit many participating companies in theUS."

From 2004 to 2007, the facial aesthetic market has grown from over $68million to over $317 million. This strong market growth has been driven byincreased public awareness and societal acceptance of minimally invasivecosmetic procedures. In North America, direct-to-consumer advertising by majorcompetitors such as Allergan and Medicis is extremely common and has resultedin high patient demand for dermal filler procedures.

MRG provides a number of products on the global facial aesthetics market.For ongoing quarterly tracking of market shares by brand, MRG offers itsMarketrack service, which tracks facial aesthetic products -- such asbotulinum toxin, HA, collagen, and particle and polymer injectables -- in theUS and Canada. Furthermore, the project has been expanded to include trackingof breast implant procedures in US plastic surgery facilities. Besides marketshare, this service also provides brand-level usage (units, average sellingprice, and revenue), detailed procedure numbers, and practitioner practiceinformation.

For in-depth analysis and five-year growth forecasts, MRG offers itsGlobal Markets for Facial Aesthetics 2007 report series, which includesindividual reports on the US, Europe, Asia Pacific, Canada, Brazil, andMexico. Companies covered by MRG facial aesthetics market research includeAllergan, Solstice Neurosciences, Ipsen, Q-Med, Medicis, Bioform Medical Inc.,Dermik Labs, Sanofi-Aventis, Mentor, Teoxane, Lifecell, Fascia Biosystems, andArtes Medical.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc.company (www.DecisionResources.com), is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.

All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 akrohn@mrg.net

SOURCE Millennium Research Group
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Amarin Reports Third Quarter 2007 Financial Result...
S
SuperGen to Present at Lazard Capital Markets Four...